Profile
Joseph C.
DosSantos worked as Chief Financial Officer at MYOS RENS Technology, Inc. from 2015 to 2016.
He was Chief Financial Officer at CareCloud, Inc. in 2023.
He served as Chief Financial Officer at Luzsana Biotechnology, Inc. from 2021 to 2023.
Mr. DosSantos is expected to be Chief Financial Officer & Senior VP Finance at Celularity, Inc. from 2025 to 2026.
Mr. DosSantos completed an undergraduate degree at Kean University in 1991 and earned an MBA from Seton Hall University.
Former positions of Joseph C. DosSantos
| Companies | Position | End |
|---|---|---|
| CELULARITY INC. | Director of Finance/CFO | 27/02/2026 |
| CARECLOUD, INC. | Director of Finance/CFO | 10/05/2023 |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Director of Finance/CFO | 08/05/2023 |
| MEDAVAIL HOLDINGS, INC. | Chief Executive Officer | 17/12/2015 |
Training of Joseph C. DosSantos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MYOS RENS Technology, Inc.
MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes therapeutic products, nutritional supplements and other technologies | Health Technology |
Kean University
Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CareCloud, Inc.
CareCloud, Inc. Packaged SoftwareTechnology Services Provides healthcare information technology solutions | Technology Services |
Celularity, Inc.
Celularity, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that discovers cancer sub-types and therapeutic options for cancer patients | Commercial Services |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
- Stock Market
- Insiders
- Joseph C. DosSantos
















